KKR

Kohlberg Kravis Roberts

$100.83

+2.04%
Sep 21, 2026
Bobby Quantitative Model
KKR & Co. Inc. is one of the world's largest alternative asset managers, overseeing $723.2 billion in total managed assets (including $585.0 billion in fee-earning AUM as of September 2025) across two core segments: asset management (private equity, credit, infrastructure, energy, real estate, and public markets) and insurance, following its acquisition of Global Atlantic Financial Group. With roughly 4,200 employees and a market capitalization near $97.6 billion, KKR stands as a bellwether of the alternative asset management industry alongside peers like Blackstone and Apollo, distinguished by its integrated 'one-firm' model that pairs permanent capital from insurance with high-fee private markets strategies. The current investor narrative centers on KKR's aggressive push into AI-adjacent digital infrastructure — highlighted by the June 2026 launch of Helix Digital Infrastructure with $10 billion in backing — and the potential opening of the $14 trillion 401(k) market to private credit, both of which could meaningfully expand fee-earning AUM. However, this optimism is tempered by a sharp year-to-date share price decline of roughly 23%, reflecting broader concerns about private credit valuations, elevated interest expenses, and lumpy quarterly earnings that swung from a loss in Q1 2025 to strong profitability in subsequent quarters.

People also watch

Direxion Daily S&P 500  Bull 3x ETF

Direxion Daily S&P 500 Bull 3x ETF

SPXL

Analysis
Strive, Inc. Variable Rate Series A Perpetual Preferred Stock

Strive, Inc. Variable Rate Series A Perpetual Preferred Stock

SATA

Analysis
Franklin International Core Dividend Tilt Index ETF

Franklin International Core Dividend Tilt Index ETF

DIVI

Analysis
Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X ETF

LABU

Analysis
ProShares Ultra Semiconductors

ProShares Ultra Semiconductors

USD

Analysis

BobbyInvestment Opinion: Should I buy KKR Today?

Rating: Hold with a bias toward accumulation on weakness. The core thesis is that KKR's forward valuation of 13.34x earnings is attractive for a franchise with $723.2 billion in AUM and a 30.2% upside to the average analyst target of $128.67, but near-term earnings visibility is poor and the stock is in a pronounced downtrend. The analyst consensus rating of 1.59 (buy) and the average target of $128.67 anchor a constructive view, yet the 33.84% one-year decline and 23.34% YTD drop suggest the market is pricing in significant risks that may not be fully reflected in estimates.

Supporting evidence for a constructive stance includes: (1) forward PE of 13.34x versus trailing PE of 50.79x, implying a dramatic earnings recovery to $9.71 EPS; (2) revenue growth of 31% YoY in Q1 2026, with the insurance segment providing $2.29 billion of recurring revenue; (3) trailing free cash flow of $6.89 billion, demonstrating strong cash generation; and (4) a dividend yield of 0.68% with a conservative payout ratio of 32.4%, leaving room for growth. The PB ratio of 3.67x is above the historical median but well below the 5.55x peak, suggesting the stock has already de-rated significantly. The implied upside to the average target is 30.2%, and even the low target of $115 offers 16.4% upside.

The biggest risks that could invalidate the thesis are: (1) a continued decline in private equity realizations that keeps operating margins below 10%, (2) credit markdowns in the insurance portfolio due to rising rates or defaults, and (3) a breakdown below the 52-week low of $82.67 that triggers accelerated selling. The rating would upgrade to Buy if the stock stabilizes above $100 and Q3 2026 earnings show operating margin recovery above 15%, or if the forward PE compresses below 12x without a corresponding decline in estimates. It would downgrade to Sell if revenue growth decelerates below 10% or if the insurance segment reports a quarterly loss. Relative to its own history, KKR appears undervalued on a forward basis, but the market is demanding evidence of sustainable earnings before re-rating the stock.

Sign up to view all

KKR 12-Month Price Forecast

KKR presents a classic value-versus-momentum dilemma: the forward valuation is compelling at 13.34x earnings, and the 30.2% upside to the average analyst target suggests the market is overly pessimistic. However, the stock is in a severe downtrend, operating margins are thin, and the earnings recovery embedded in estimates is not yet visible in quarterly results. The Helix Digital Infrastructure launch and the potential 401(k) opportunity are genuine long-term catalysts, but they are unlikely to materially impact earnings within the next 12 months. I would upgrade to bullish if Q3 2026 earnings show operating margin above 15% and EPS above $2.50, or if the stock reclaims $115 on strong volume. I would downgrade to bearish if the stock breaks below $82.67 or if the insurance segment reports a quarterly loss.

Historical Price
Current Price $100.83
Average Target $125.00
High Target $166.00
Low Target $82.67

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Kohlberg Kravis Roberts's 12-month outlook, with a consensus price target around $128.67 and implied upside of +27.6% versus the current price.

Average Target

$128.67

0 analysts

Implied Upside

+27.6%

vs. current price

Analyst Count

covering this stock

Price Range

$115 - $166

Analyst target range

KKR is covered by 20 analysts with a consensus recommendation of 'buy' (recommendation mean of 1.59 on a 1-5 scale where 1 is Strong Buy), reflecting broad institutional optimism despite the stock's poor price performance. The average target price of $128.67 implies 30.2% upside from the current price of $98.81, a substantial gap that suggests analysts believe the market is significantly undervaluing the franchise — or that their estimates are stale relative to the recent sell-off. The consensus leans decidedly bullish, with the recommendation mean of 1.59 indicating that the overwhelming majority of covering analysts rate the stock a Buy or Outperform; recent institutional ratings from Evercore ISI, BMO Capital, RBC Capital, Barclays, and UBS all reaffirmed Outperform/Overweight/Buy ratings as of July 2026, with no downgrades visible in the provided data. The target price range spans from a low of $115.00 to a high of $166.00, a spread of $51.00 or approximately 44% of the low target, which signals meaningful disagreement about the company's trajectory. The high target of $166.00 (68.0% upside) likely assumes successful deployment of the Helix Digital Infrastructure platform, continued AUM growth from the 401(k) private credit opportunity, and a normalization of realizations that drives EPS toward the high end of the $8.96-$10.35 estimated range. The low target of $115.00 (16.4% upside) still implies meaningful appreciation but likely prices in a more conservative scenario with slower fundraising, compressed performance fees, and potential credit markdowns in the insurance portfolio. The estimated EPS average of $9.71 for the forward period, against a trailing EPS of just $0.02, underscores the dramatic earnings recovery analysts expect — a recovery that, if delivered, would make the current forward PE of 13.34x look exceptionally cheap for a franchise of KKR's scale and market position.

Drowning in data?

Find the real signal!

Bulls vs Bears: KKR Investment Factors

The bear case currently has stronger near-term evidence, given the 33.84% one-year decline, the stock's position just 11.2% above its 52-week low, and operating margins that collapsed to 5.1% in Q1 2026. However, the bull case rests on a compelling forward valuation — a 13.34x forward PE against estimated EPS of $9.71 — and a 30.2% upside to the average analyst target of $128.67, suggesting the market may be overly discounting the franchise. The single most important tension is whether the forward earnings recovery is real: if KKR delivers on the $9.71 EPS estimate, the stock is deeply undervalued; if realizations remain lumpy and the insurance segment drags, the low target of $115 could prove optimistic. The resolution of this debate likely hinges on Q3 2026 earnings and the pace of Helix Digital Infrastructure deployment.

Bullish

  • Analyst consensus sees 30% upside: 20 analysts rate KKR a 'buy' with a recommendation mean of 1.59, and the average target price of $128.67 implies 30.2% upside from the current $98.81. Even the lowest target of $115.00 offers 16.4% upside, suggesting the sell-off has overshot fundamentals.
  • Forward PE of 13.3x is historically cheap: The forward PE of 13.34x sits near the low end of KKR's historical range (7.85x–282.9x), while the trailing PE of 50.79x is distorted by the loss-making Q1 2025. Analysts expect EPS to recover to $9.71, which would make the current multiple look exceptionally attractive for a franchise with $723.2B in AUM.
  • Robust free cash flow generation: KKR generated $6.89 billion in trailing twelve-month free cash flow, with $1.90 billion in the most recent quarter alone. This cash-generative model supports continued fund seeding, dividend growth, and balance sheet flexibility despite the 1.77 debt-to-equity ratio.
  • AI infrastructure and 401(k) catalysts: The June 2026 launch of Helix Digital Infrastructure with $10 billion in backing positions KKR to capture AI-driven digital infrastructure demand. Separately, the potential opening of the $14 trillion 401(k) market to private credit could significantly expand fee-earning AUM beyond the current $585 billion.

Bearish

  • Severe price downtrend and underperformance: KKR is down 33.84% over the past year and 23.34% year-to-date, sitting just 11.2% above its 52-week low of $82.67. The stock has lagged SPY by 48.85 percentage points over one year, signaling persistent institutional selling and a lack of conviction.
  • Thin operating margins and high interest burden: Q1 2026 operating margin was just 5.1%, with interest expense of $752.1 million exceeding operating income of $205.4 million. The trailing operating margin of 2.6% is well below the 40.0% achieved in Q4 2025, highlighting extreme earnings cyclicality.
  • Elevated leverage limits flexibility: Debt-to-equity of 1.77 and total debt-to-capitalization of 64.3% leave limited margin for error if credit conditions tighten. The insurance segment's spread-based earnings introduce interest-rate sensitivity, and ROE of just 7.67% is modest relative to the cost of equity.
  • Lumpy earnings make valuation difficult: Revenue swung from $5.52 billion in Q4 2025 to $4.00 billion in Q1 2026, a 27.5% sequential decline, and net income ranged from a -$185.9 million loss in Q1 2025 to $1.15 billion in Q4 2025. This volatility makes forward estimates unreliable and can trigger sharp price reactions.

KKR Technical Analysis

KKR is in a pronounced downtrend on a trailing twelve-month basis, with the stock down 33.84% over the past year and sitting at $98.81 — just 11.2% above its 52-week low of $82.67 and a staggering 35.0% below its 52-week high of $152.10. At approximately 23% of its 52-week range, the stock is positioned deep in the lower quartile, which typically signals either a value opportunity for contrarian investors or a falling knife if fundamental deterioration persists. The magnitude of the drawdown — a max drawdown of -43.83% — underscores the severity of the de-rating, and the stock's failure to reclaim even the midpoint of its range suggests persistent selling pressure and a lack of institutional conviction at current levels. Recent momentum offers a mixed picture: while the 1-month change is -10.55%, the 3-month change is +1.86% and the 6-month change is +9.79%, indicating that the stock staged a meaningful recovery from its lows earlier in 2026 before rolling over again in September. This divergence — positive 3-month and 6-month returns against a sharply negative 1-month reading — suggests the recovery rally has stalled and the stock is retesting support, potentially forming a lower high relative to the August peak of $115.30. The relative strength figures reinforce the underperformance: KKR has lagged SPY by 9.59 percentage points over the past month and by a staggering 48.85 percentage points over the past year, a level of underperformance that often precedes mean-reversion but can also signal structural headwinds. Key technical levels to monitor are the 52-week low at $82.67 as critical support — a breakdown below this level would likely trigger accelerated selling and open the door to new lows — and the August swing high of $115.30 as near-term resistance, with the 52-week high of $152.10 representing the longer-term ceiling. A beta of 1.791 means KKR is approximately 79% more volatile than the S&P 500, which has profound implications for position sizing: in a risk-off environment, this stock will amplify market declines, and the 2.87 short ratio suggests bears are not aggressively positioned but the elevated volatility warrants careful risk management.

Beta

1.79

1.79x market volatility

Max Drawdown

-43.8%

Largest decline past year

52-Week Range

$83-$152

Price range past year

Annual Return

-32.3%

Cumulative gain past year

PeriodKKR ReturnS&P 500
1m-7.1%+1.0%
3m+7.8%+5.4%
6m+13.4%+17.8%
1y-32.3%+16.5%
ytd-21.8%+13.4%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

KKR Fundamental Analysis

KKR's revenue trajectory has been volatile but directionally positive, with Q1 2026 revenue of $4.00 billion representing 31% year-over-year growth from Q1 2025's $3.05 billion, which itself was a trough quarter that produced a net loss of -$185.9 million. The multi-quarter trend reveals significant lumpiness: revenue surged to $5.52 billion in Q4 2025 (driven by strong realizations and insurance segment contributions) before moderating to $4.00 billion in Q1 2026, a sequential decline of 27.5% that reflects the inherently episodic nature of private equity realizations and performance fees. Segment data shows the Insurance segment contributed $2.29 billion and Asset Management & Strategic Holdings $2.03 billion, with the Asset Management segment alone adding $1.19 billion — the insurance business now represents a substantial and growing share of total revenue, providing more recurring, fee-based income but also introducing spread-based earnings volatility tied to interest rates. The key question for investors is whether the 31% YoY growth rate is sustainable or flattered by an easy comparison against a loss-making quarter; the analyst consensus revenue estimate of $9.74 billion for the forward period implies continued expansion but at a more moderate pace. Profitability has improved materially from the Q1 2025 loss, with Q1 2026 net income of $405.2 million translating to a net margin of 10.1% and a gross margin of 99.5% (though this latter figure is somewhat misleading for a financial firm where cost of revenue is minimal). The more relevant profitability metric is the operating margin, which stood at just 5.1% in Q1 2026 — thin for an asset manager — reflecting the heavy compensation and interest expense burden; interest expense alone was $752.1 million in the quarter, consuming more than the entire operating income of $205.4 million. On a trailing basis, the net margin is 12.3% and the operating margin is just 2.6%, both well below what KKR has historically achieved in strong realization environments (Q4 2025 saw a 20.8% net margin and 40.0% operating margin), highlighting the earnings cyclicality that makes valuation challenging. The balance sheet carries meaningful leverage with a debt-to-equity ratio of 1.77 and total debt-to-capitalization of 64.3%, which is typical for an asset manager that uses its balance sheet to seed funds and support the insurance business, but leaves limited margin for error if credit conditions tighten. Free cash flow is robust at $6.89 billion on a trailing twelve-month basis, and the most recent quarter generated $1.90 billion in FCF against $1.93 billion in operating cash flow, demonstrating the cash-generative nature of the business model. However, the current ratio of 79.85 is anomalously high and reflects the insurance segment's large investment portfolio rather than traditional liquidity, while the ROE of just 7.67% is modest relative to the company's historical performance and cost of equity, suggesting the market is not being compensated for the leverage and cyclicality embedded in the business.

Quarterly Revenue

$4.0B

2026-03

Revenue YoY Growth

+31.0%

YoY Comparison

Gross Margin

99.5%

Latest Quarter

Free Cash Flow

$6.9B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Asset Management And Strategic Holdings Segments
Asset Management Segment
Insurance Segment

Open an Account, get $2 TSLA now!

Valuation Analysis: Is KKR Overvalued?

With trailing net income positive at approximately $1.9 billion (TTM), the PE ratio is the appropriate primary valuation metric, and KKR's trailing PE of 50.79x appears optically expensive — but this is heavily distorted by the loss-making Q1 2025 quarter and the lumpy nature of private equity earnings. The forward PE of 13.34x tells a dramatically different story, implying the market expects earnings to more than triple as realizations normalize and the insurance segment scales; the gap between 50.79x trailing and 13.34x forward is one of the widest in the large-cap financials universe and signals either a compelling value opportunity or skepticism about the sustainability of forward estimates. The PEG ratio of -1.84 is not meaningful given the negative earnings growth base effect, and the PS ratio of 5.91x and EV/EBITDA of 16.54x provide additional context for a capital-intensive financial business. Compared to the broader Asset Management industry, KKR's forward PE of 13.34x is difficult to benchmark precisely without explicit sector averages in the provided data, but the PB ratio of 3.67x and PS ratio of 5.91x suggest the stock is not trading at distressed levels despite the price decline. The dividend yield of just 0.68% with a payout ratio of 32.4% indicates KKR remains a growth-oriented allocator of capital rather than an income play, which is consistent with its peer group. Historically, KKR's PE ratio has ranged from as low as 7.85x (Q3 2021) to as high as 282.9x (Q3 2022, during an earnings trough), with the current 50.79x trailing PE sitting in the upper-middle of that range but the 13.34x forward PE near the lower end of historical norms. The PB ratio of 3.67x is above the historical median of approximately 3.2-4.0x but well below the 5.55x peak in Q4 2024, suggesting the market has already de-rated the stock significantly from its premium valuation. The EV/EBITDA multiple of 16.54x compares to a historical range of roughly 12x to 113x, placing the current valuation in the lower half of its own band — a potentially constructive signal for value-oriented investors willing to tolerate earnings volatility.

PE

50.8x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 7x~63x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

16.5x

Enterprise Value Multiple

Investment Risk Disclosure

KKR's financial and operational risks are substantial. The debt-to-equity ratio of 1.77 and total debt-to-capitalization of 64.3% reflect a balance sheet heavily reliant on leverage, with interest expense of $752.1 million in Q1 2026 alone exceeding operating income of $205.4 million. Operating margins have been volatile, ranging from -23.1% in Q1 2025 to 40.0% in Q4 2025, and the trailing operating margin of 2.6% is thin for an asset manager. Revenue is concentrated in cyclical private equity realizations and the growing insurance segment, which now contributes $2.29 billion of the $4.00 billion quarterly total, introducing spread-based earnings volatility tied to interest rates. The ROE of 7.67% is modest relative to the cost of equity, suggesting the company is not generating sufficient returns to justify its leverage.

Market and competitive risks are amplified by KKR's premium valuation relative to its own history and its high beta. The forward PE of 13.34x may appear cheap, but the trailing PE of 50.79x and PB ratio of 3.67x indicate the stock is not distressed; a further de-rating could occur if private credit valuations face markdowns or if the 401(k) private credit opportunity is delayed by regulation. The beta of 1.791 means KKR is 79% more volatile than the S&P 500, so any macro risk-off event would disproportionately impact the shares. Recent news highlights both opportunity and threat: the Helix Digital Infrastructure launch with $10 billion in backing is a long-term catalyst, but the stock faces significant technical resistance, and a downgrade wave in bank stocks suggests rotation away from financials could pressure alternative asset managers. Competitive pressure from Blackstone and Apollo in the race for 401(k) assets and AI infrastructure could compress fees.

The worst-case scenario would involve a combination of credit deterioration in the insurance portfolio, a slowdown in private equity realizations, and a broader market sell-off that compresses multiples. In this scenario, KKR could retest its 52-week low of $82.67, representing a 16.3% decline from the current price of $98.81. If the low analyst target of $115 is breached and the stock breaks below $82.67, the next support could be significantly lower, potentially approaching the historical max drawdown of -43.83% from the 52-week high of $152.10, which would imply a price near $85.50. A more severe outcome, such as a credit event in the insurance segment or a failed Helix deployment, could push the stock toward $70, a 29% loss from current levels. Investors should size positions accordingly, given the high beta and the potential for accelerated selling below key support.

FAQ

The most severe risk is financial: debt-to-equity of 1.77 and interest expense of $752.1 million per quarter exceed operating income, leaving little margin for error if credit conditions tighten. Second, earnings volatility is extreme, with net income swinging from a -$185.9 million loss in Q1 2025 to $1.15 billion in Q4 2025, making forward estimates unreliable. Third, competitive and market risks include a high beta of 1.791, which amplifies market declines, and the potential for private credit markdowns in the insurance portfolio. Fourth, company-specific risks include the lumpy nature of private equity realizations and the execution risk of the Helix Digital Infrastructure initiative. Ranked by severity, the financial leverage and interest burden pose the greatest threat, followed by earnings volatility and market sensitivity.

The 12-month forecast is divided into three scenarios: a base case (50% probability) with a target range of $115–$135, assuming EPS of $9.71 and a forward PE of 13–14x; a bull case (25% probability) with a target range of $140–$166, driven by successful Helix deployment and 401(k) expansion; and a bear case (25% probability) with a target range of $82.67–$100, triggered by credit markdowns and depressed realizations. The base case is most likely, as it aligns with the analyst average target of $128.67 and consensus EPS estimates. The key assumption is that operating margins recover to 10–15% and no major credit events occur. However, the wide target range reflects significant uncertainty.

KKR appears undervalued on a forward basis but fairly valued to slightly expensive on trailing metrics. The forward PE of 13.34x is well below the trailing PE of 50.79x, reflecting the market's expectation of a dramatic earnings recovery from the loss-making Q1 2025. The PB ratio of 3.67x is above the historical median of 3.2–4.0x but below the 5.55x peak, suggesting the stock has already de-rated significantly. The PS ratio of 5.91x and EV/EBITDA of 16.54x are in the lower half of their historical ranges. If the forward EPS estimate of $9.71 is achieved, the stock is cheap; if estimates are cut, the valuation could prove optimistic. The market is currently pricing in skepticism about the sustainability of the earnings recovery.

From a risk/reward perspective, KKR is a speculative buy for investors with a long time horizon and high risk tolerance. The stock trades at $98.81, implying 30.2% upside to the average analyst target of $128.67, and the forward PE of 13.34x is near the low end of its historical range. However, the stock is down 33.84% over the past year and sits just 11.2% above its 52-week low of $82.67, with a beta of 1.791 that amplifies market declines. The biggest downside risk is a break below $82.67, which could push the stock toward $70, a 29% loss. For patient investors who believe in the earnings recovery to $9.71 EPS, the risk/reward is favorable, but position sizing should account for the high volatility.

KKR is better suited for long-term investment than short-term trading, given its high beta of 1.791, lumpy quarterly earnings, and the multi-year nature of its growth catalysts. The stock's 33.84% one-year decline and max drawdown of -43.83% illustrate the risks of short-term holding, while the forward PE of 13.34x and 30.2% upside to analyst targets suggest meaningful long-term appreciation potential. The dividend yield of 0.68% is too low to provide income support, so returns depend on capital appreciation. A minimum holding period of 2–3 years is recommended to allow the earnings recovery and Helix Digital Infrastructure initiative to materialize. Short-term traders could exploit volatility around earnings, but the risk of sharp drawdowns is high.